<DOC>
	<DOC>NCT00935259</DOC>
	<brief_summary>The purpose of this study was to provide human lipidomics standards with simvastatin treatment that were to be used for comparison with similar preclinical studies.</brief_summary>
	<brief_title>Lipid Biomarker Study in Men With Dyslipidemia After Simvastatin Treatment (Study MK-0000-140)(COMPLETED)</brief_title>
	<detailed_description />
	<mesh_term>Hypercholesterolemia</mesh_term>
	<mesh_term>Dyslipidemias</mesh_term>
	<mesh_term>Simvastatin</mesh_term>
	<criteria>Participant is a Caucasian (including Hispanic) male Participant has a maximum waist size of 40 inches Participant does not currently use any lipidaltering medications Participant is in good health other than the diagnosis of dyslipidemia Participant has had stomach ulcers within the last 3 months Participant has had a heart attack in the last 6 months or has angina Participant has chronic heart failure Participant has a history of stroke, seizures, or major neurological disorder Participant has a history of cancer Participant has a gastrointestinal condition that affects bowel movements Participant has type 1 or 2 diabetes</criteria>
	<gender>Male</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>October 2015</verification_date>
	<keyword>Hypercholesterolemia, Dyslipidemia, simvastatin, Zocor</keyword>
</DOC>